123 related articles for article (PubMed ID: 9768369)
1. Antibodies to glutamic acid decarboxylase (GAD) in non-obese Japanese diabetics without insulin therapy: a comparison of two commercial RIA kits based on recombinant and pig brain GAD.
Bando Y; Ushiogi Y; Toya D; Tanaka N; Fujisawa M
Diabetes Res Clin Pract; 1998 Jul; 41(1):25-33. PubMed ID: 9768369
[TBL] [Abstract][Full Text] [Related]
2. Clinical and Genetic Characteristics of Non-Insulin-Requiring Glutamic Acid Decarboxylase (GAD) Autoantibody-Positive Diabetes: A Nationwide Survey in Japan.
Yasui J; Kawasaki E; Tanaka S; Awata T; Ikegami H; Imagawa A; Uchigata Y; Osawa H; Kajio H; Kawabata Y; Shimada A; Takahashi K; Yasuda K; Yasuda H; Hanafusa T; Kobayashi T;
PLoS One; 2016; 11(5):e0155643. PubMed ID: 27177031
[TBL] [Abstract][Full Text] [Related]
3. Antibodies to GAD in Japanese diabetic patients: a multicenter study.
Tsuruoka A; Matsuba I; Toyota T; Isshiki G; Nagataki S; Ikeda Y
Diabetes Res Clin Pract; 1995 Jun; 28(3):191-9. PubMed ID: 8529498
[TBL] [Abstract][Full Text] [Related]
4. [GAD antibody in IDDM].
Yokota I; Shima K
Rinsho Byori; 1998 Apr; 46(4):331-7. PubMed ID: 9594623
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance and time course of antibodies to glutamic acid decarboxylase in Japanese children with type I (insulin-dependent) diabetes mellitus.
Sugihara S; Konda S; Wataki K; Kobayashi Y; Murata A; Miyamoto S; Kubo H; Yamaguchi A; Sasaki N; Niimi H
Acta Paediatr; 1996 May; 85(5):558-63. PubMed ID: 8827099
[TBL] [Abstract][Full Text] [Related]
6. [The glutamic acid decarboxylase (GAD) antibodies and their clinical significance].
Ogata K; Ohta K; Kubo H; Yamaguchi A; Watanabe H
Rinsho Byori; 1995 May; 43(5):468-71. PubMed ID: 7783365
[TBL] [Abstract][Full Text] [Related]
7. Adult-onset autoimmune diabetes identified by glutamic acid decarboxylase autoantibodies: a retrospective cohort study.
Wada E; Onoue T; Kinoshita T; Hayase A; Handa T; Ito M; Furukawa M; Okuji T; Kobayashi T; Iwama S; Sugiyama M; Takagi H; Hagiwara D; Suga H; Banno R; Goto M; Arima H
Diabetologia; 2021 Oct; 64(10):2183-2192. PubMed ID: 34268631
[TBL] [Abstract][Full Text] [Related]
8. Clinical, autoimmune, and genetic characteristics of adult-onset diabetic patients with GAD autoantibodies in Japan (Ehime Study).
Takeda H; Kawasaki E; Shimizu I; Konoue E; Fujiyama M; Murao S; Tanaka K; Mori K; Tarumi Y; Seto I; Fujii Y; Kato K; Kondo S; Takada Y; Kitsuki N; Kaino Y; Kida K; Hashimoto N; Yamane Y; Yamawaki T; Onuma H; Nishimiya T; Osawa H; Saito Y; Makino H;
Diabetes Care; 2002 Jun; 25(6):995-1001. PubMed ID: 12032105
[TBL] [Abstract][Full Text] [Related]
9. Clinical evaluation of non-insulin-dependent diabetes mellitus patients with autoantibodies to glutamic acid decarboxylase.
Abiru N; Takino H; Yano M; Kawasaki E; Yamasaki H; Yamaguchi Y; Akazawa S; Nagataki S
J Autoimmun; 1996 Oct; 9(5):683-8. PubMed ID: 8933285
[TBL] [Abstract][Full Text] [Related]
10. Antigenic differences between neurological and diabetic patients with anti-glutamic acid decarboxylase antibodies.
Vianello M; Keir G; Giometto B; Betterle C; Tavolato B; Thompson EJ
Eur J Neurol; 2005 Apr; 12(4):294-9. PubMed ID: 15804247
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late-onset insulin-dependent diabetes mellitus, and polyendocrine autoimmunity.
Saiz A; Arpa J; Sagasta A; Casamitjana R; Zarranz JJ; Tolosa E; Graus F
Neurology; 1997 Oct; 49(4):1026-30. PubMed ID: 9339684
[TBL] [Abstract][Full Text] [Related]
12. Anti-GAD antibodies in Chinese patients with youth and adult-onset IDDM and NIDDM.
Thai AC; Ng WY; Loke KY; Lee WR; Lui KF; Cheah JS
Diabetologia; 1997 Dec; 40(12):1425-30. PubMed ID: 9447950
[TBL] [Abstract][Full Text] [Related]
13. Discrepancy of glutamic acid decarboxylase 65 autoantibody results between RSR radioimmunoassay and enzyme-linked immunosorbent assay in patients with type 1 diabetes is related to autoantibody affinity.
Kawasaki E; Okada A; Uchida A; Fukuyama T; Sagara Y; Nakano Y; Tamai H; Tojikubo M; Koga N
J Diabetes Investig; 2019 Jul; 10(4):990-996. PubMed ID: 30582775
[TBL] [Abstract][Full Text] [Related]
14. Increased diagnosis of autoimmune childhood-onset Japanese type 1 diabetes using a new glutamic acid decarboxylase antibody enzyme-linked immunosorbent assay kit, compared with a previously used glutamic acid decarboxylase antibody radioimmunoassay kit.
Sugihara S; Yokota I; Mukai T; Mochizuki T; Nakayama M; Tachikawa E; Kawada Y; Minamitani K; Kikuchi N; Urakami T; Kawamura T; Kawasaki E; Kikuchi T; Amemiya S;
J Diabetes Investig; 2020 May; 11(3):594-602. PubMed ID: 31756289
[TBL] [Abstract][Full Text] [Related]
15. Detection of recombinant GAD65 and GAD67 antibodies using a simple radioimmunoassay.
Kawasaki E; Yano M; Abiru N; Akazawa S; Nagataki S
Diabetes Res Clin Pract; 1996 Apr; 32(1-2):61-9. PubMed ID: 8803483
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies to IA-2 and GAD65 in patients with type 2 diabetes mellitus of varied duration: prevalence and correlation with clinical features.
Grasso YZ; Reddy SK; Rosenfeld CR; Hussein WI; Hoogwerf BJ; Faiman C; Gupta MK
Endocr Pract; 2001; 7(5):339-45. PubMed ID: 11585368
[TBL] [Abstract][Full Text] [Related]
17. Autoantibodies against glutamic acid decarboxylase 65 in Japanese patients with insulin-dependent diabetes mellitus (IDDM).
Yano M; Moriuchi R; Kawasaki E; Watanabe M; Saito K; Takino H; Akazawa S; Miyamoto T; Nagataki S
J Autoimmun; 1995 Feb; 8(1):83-96. PubMed ID: 7734039
[TBL] [Abstract][Full Text] [Related]
18. Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies.
Tuomi T; Carlsson A; Li H; Isomaa B; Miettinen A; Nilsson A; Nissén M; Ehrnström BO; Forsén B; Snickars B; Lahti K; Forsblom C; Saloranta C; Taskinen MR; Groop LC
Diabetes; 1999 Jan; 48(1):150-7. PubMed ID: 9892237
[TBL] [Abstract][Full Text] [Related]
19. Clinical and genetic characteristics of diabetic patients with high-titer (>10,000 U/ml) of antibodies to glutamic acid decarboxylase.
Ishii M; Hasegawa G; Fukui M; Obayashi H; Ohta M; Ogata M; Yoshioka K; Kitagawa Y; Nakano K; Yoshikawa T; Nakamura N
Immunol Lett; 2005 Jul; 99(2):180-5. PubMed ID: 16009268
[TBL] [Abstract][Full Text] [Related]
20. Antibodies to glutamic acid decarboxylase in at-risk and clinical insulin-dependent diabetic subjects: relationship to age, sex and islet cell antibody status, and temporal profile.
Schmidli RS; DeAizpurua HJ; Harrison LC; Colman PG
J Autoimmun; 1994 Feb; 7(1):55-66. PubMed ID: 8198702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
